|
|
||||||||
The Journal of Immunology, Vol 140, Issue 3 737-743, Copyright © 1988 by American Association of Immunologists
ARTICLES |
A Hamann, D Jablonski-Westrich, KU Scholz, A Duijvestijn, EC Butcher and HG Thiele
Abteilung fur Klinische Immunologie, Universitatskrankenhaus Eppendorf, Hamburg, West Germany.
Upon activation, lymphocytes display profound alterations in their in vivo migration behavior. In an attempt to understand some of the cellular mechanisms responsible for this altered behavior, in vitro stimulated lymphocytes have been analyzed for their expression of a putative homing receptor (HOR) (defined by mAb MEL-14) and for their ability to bind to specialized lymphoid organ high endothelial venules (HEV) in vitro. The results indicate that signals related to lymphocyte activation induce complex alterations in HOR expression and organ- specificity of HEV-binding: 1) submitogenic stimuli induce an increase in MEL-14 antigen expression. This applies to almost all lymphocytes in autologous cultures, for the fraction of cells in periodate, LPS- or Con A-treated cultures not fully activated and for cultures stimulated with suboptimal doses of Con A. 2) Full blast transformation is associated with a decrease or complete loss of MEL-14 antigen expression on the majority of blasts in all activating systems used, but a subset of up to 30 to 40% of fully activated cells may nonetheless express very high levels of the MEL-14 antigen. 3) Functional assays reveal that Con A and periodate stimulation lead to a selective, nearly complete suppression of the lymphocytes binding to HEV of Peyer's patches, even under conditions where overall binding to peripheral node HEV is increased. This indicates a differential regulation of the two respective receptors, with the mucosa system- specific HOR being more prone to down-regulation during in vitro activation by these mitogens.
This article has been cited by other articles:
![]() |
S. Rana, S. N. Byrne, L. J. MacDonald, C. Y.-Y. Chan, and G. M. Halliday Ultraviolet B Suppresses Immunity by Inhibiting Effector and Memory T Cells Am. J. Pathol., April 1, 2008; 172(4): 993 - 1004. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. R. Waters, M. V. Palmer, D. L. Whipple, R. E. Slaughter, and S. L. Jones IMMUNE RESPONSES OF WHITE-TAILED DEER (ODOCOILEUS VIRGINIANUS) TO MYCOBACTERIUM BOVIS BCG VACCINATION J. Wildl. Dis., January 1, 2004; 40(1): 66 - 78. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. R. Waters, T. E. Rahner, M. V. Palmer, D. Cheng, B. J. Nonnecke, and D. L. Whipple Expression of L-Selectin (CD62L), CD44, and CD25 on Activated Bovine T Cells Infect. Immun., January 1, 2003; 71(1): 317 - 326. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Porter and N. A. Clipstone Sustained NFAT Signaling Promotes a Th1-Like Pattern of Gene Expression in Primary Murine CD4+ T Cells J. Immunol., May 15, 2002; 168(10): 4936 - 4945. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Jones, S. C. Cose, J. M. McNally, S. R. Jennings, W. R. Heath, and F. R. Carbone Diminished secondary CTL response in draining lymph nodes on cutaneous challenge with herpes simplex virus J. Gen. Virol., February 1, 2000; 81(2): 407 - 414. [Abstract] [Full Text] |
||||
![]() |
R. Hokari, S. Miura, H. Fujimori, S. Koseki, Y. Tsuzuki, H. Kimura, H. Higuchi, H. Serizawa, D. N. Granger, and H. Ishii Altered migration of gut-derived T lymphocytes after activation with concanavalin A Am J Physiol Gastrointest Liver Physiol, October 1, 1999; 277(4): G763 - G772. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kagamu and S. Shu Purification of L-Selectinlow Cells Promotes the Generation of Highly Potent CD4 Antitumor Effector T Lymphocytes J. Immunol., April 1, 1998; 160(7): 3444 - 3452. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Salmi, S. Tohka, E. L. Berg, E. C. Butcher, and S. Jalkanen Vascular Adhesion Protein 1 (VAP-1) Mediates Lymphocyte Subtype-specific, Selectin-independent Recognition of Vascular Endothelium in Human Lymph Nodes J. Exp. Med., August 18, 1997; 186(4): 589 - 600. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |